Ih. Jonsdottir et al., DURATION AND MECHANISMS OF THE INCREASED NATURAL CYTOTOXICITY SEEN AFTER CHRONIC VOLUNTARY EXERCISE IN RATS, Acta Physiologica Scandinavica, 160(4), 1997, pp. 333-339
We have recently shown that in vivo natural cytotoxicity is enhanced a
fter chronic exercise in spontaneously hypertensive rats (SHRs). In th
e present report, we have studied the duration of this augmentation an
d some possible mechanisms involved. Exercise consisted of voluntary r
unning for 4-5 weeks, with the running distance ranging from 2.7-15.6
km day(-1) during the last week of running. in vivo cytotoxicity was m
easured as clearance of injected Cr-51-labelled YAC-1 lymphoma cells f
rom the lungs. The in vivo natural cytotoxicity was increased in runni
ng SHRs, and also in SHRs that had their running wheel locked for 24 a
nd 48 h prior to the experiment, and was still present after 96 h. The
enhancement of in vivo cytotoxicity after 5 weeks of exercise was abo
lished after an acute injection of the P-adrenergic receptor antagonis
t timolol (0.5 mg kg(-1) i.v.), indicating that catecholamines are inv
olved in this augmentation. interestingly. 24 h after the last exercis
e bout, the increased natural cytotoxicity could be blocked by timolol
. The opioid receptor antagonist naloxone given subcutaneously for 7 d
ays by osmotic pumps (6 mg kg(-1) h(-1)) could not reverse the increas
ed in vivo cytotoxicity seen in the running SHRs, suggesting that opio
id receptor mechanisms are not involved, or at least not the naloxone-
sensitive mu-receptor. Natural immunity was not influenced by the hist
amine H-2 receptor antagonist ranitidine. either in controls or in run
ners, indicating that the natural killer cell-regulatory effect of his
tamine is not present in SHRs and does not seem to be involved in the
exercise-induced changes in natural immune function. We conclude that
the augmentation of in vivo natural cytotoxicity after voluntary chron
ic exercise in rats is long-lasting and that the augmentation is partl
y mediated by beta-adrenergic receptors.